Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 32, Number 10—October 2026
Dispatch
Clinical Characterization of Invasive Meningococcal Disease Epidemic, Uzbekistan, 2026
Table 2
Clinical predictors of fatal outcome determined by univariable and multivariable analyses in study of invasive meningococcal disease epidemic in Tashkent, Uzbekistan, 2026*
| Variable | CFR present, % | CFR absent, % | Crude OR (95% CI) | Adjusted OR (95% CI) | p value |
|---|---|---|---|---|---|
| Clinical signs, univariable | |||||
| Meningeal signs | 50.0 | 7.9 | 11.65 (2.71–50.13) | NA | 0.003† |
| Loss of consciousness | 8.8 | 9.8 | 0.89 (0.38–2.08) | NA | 0.785 |
| Hemorrhagic rash | 9.3 | 9.1 | 1.02 (0.43–2.43) | NA | 0.964 |
| Fever >38°C | 9.3 | 9.1 | 1.02 (0.43–2.43) | NA | 0.964 |
| Vomiting |
8.2 |
10.7 |
0.75 (0.32–1.75) |
NA |
0.503 |
| Multivariable logistic regression‡ | |||||
| Age at onset, 12 mo. | 1.06 (1.02–1.11) | 0.005 | |||
| Sterile site confirmed |
1.61 (0.50–5.15) | 0.424 | |||
*N = 261 case-patients. CFR, case fatality rate; NA, not applicable; OR, odds ratio. †Fisher exact test; all other p values determined by Pearson χ2 test. ‡Model included age at onset, sterile-site laboratory confirmation, and all 5 clinical signs. Binary signs did not converge owing to quasi-complete separation caused by the extreme rarity of meningeal signs (n = 8; 3.1%) and are not shown as adjusted OR estimates.